Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Biotech
Sionna lays off 46% of workforce to recover from CF ph. 2 fail
Sionna is laying off almost half its workforce as the company recovers from the failure of its closely watched cystic fibrosis add-on program.
James Waldron
Sep 15, 2026 7:19am
With mRNA back in the spotlight, tRNA shows potential
Aug 27, 2026 2:00pm
Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex
Aug 10, 2026 9:38am
Enterprise posts CF win, succeeding where Big Pharma stumbled
May 12, 2026 4:00am
Blackstone Invests $250M in Anagram to reduce CF pill burden
May 7, 2026 10:36am
Vertex drops Moderna-partnered inhaled CF candidate
May 4, 2026 5:48pm
